Related references
Note: Only part of the references are listed.Abnormal overexpression of G9a in melanoma cells promotes cancer progression via upregulation of the Notch1 signaling pathway
Ning-Ning Dang et al.
AGING-US (2020)
Role of Mammalian DNA Methyltransferases in Development
Zhiyuan Chen et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 89 (2020)
Tumor mutation burden and immunological, genomic, and clinicopathological factors as biomarkers for checkpoint inhibitor treatment of patients with non-small-cell lung cancer
Yuki Ozaki et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Next-generation hypomethylating agent SGI-110 primes acute myeloid leukemia cells to IAP antagonist by activating extrinsic and intrinsic apoptosis pathways
Jessica Dittman et al.
CELL DEATH AND DIFFERENTIATION (2020)
EZH2 Cooperates with DNA Methylation to Downregulate Key Tumor Suppressors and IFN Gene Signatures in Melanoma
Jessamy Tiffen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
A new methodological approach for in vitro determination of the role of DNA methylation on transcription factor binding using AlphaScreen® analysis: Focus on CREB1 binding at hBDNF promoter IV
A. Sabatucci et al.
JOURNAL OF NEUROSCIENCE METHODS (2020)
Macrophage β2-Integrins Regulate IL-22 by ILC3s and Protect from Lethal Citrobacter rodentium-Induced Colitis
Baomei Wang et al.
CELL REPORTS (2019)
PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?
Chiara Bazzichetto et al.
CANCERS (2019)
Histone Modifications and the Maintenance of Telomere Integrity
Meagan Jezek et al.
CELLS (2019)
Epigenetic Enzyme Mutations: Role in Tumorigenesis and Molecular Inhibitors
Mei Han et al.
FRONTIERS IN ONCOLOGY (2019)
A phase 1 trial of the oral DNA methyltransferase inhibitor CC-486 and the histone deacetylase inhibitor romidepsin in advanced solid tumors
Stephanie L. Gaillard et al.
CANCER (2019)
Shikonin derivatives for cancer prevention and therapy
Joelle C. Boulos et al.
CANCER LETTERS (2019)
WRN helicase is a synthetic lethal target in microsatellite unstable cancers
Edmond M. Chan et al.
NATURE (2019)
Effects of ginsenoside Rg3 on epigenetic modification in ovarian cancer cells
Lingqin Zhao et al.
ONCOLOGY REPORTS (2019)
Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy
Abdullah Al Emran et al.
TRENDS IN IMMUNOLOGY (2019)
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells
Clemens Zwergel et al.
CLINICAL EPIGENETICS (2019)
Coding or Noncoding, the Converging Concepts of RNAs
Jing Li et al.
FRONTIERS IN GENETICS (2019)
Development of a versatile DNMT and HDAC inhibitor C02S modulating multiple cancer hallmarks for breast cancer therapy
Zigao Yuan et al.
BIOORGANIC CHEMISTRY (2019)
RASSF1A is required for the maintenance of nuclear actin levels
Maria Chatzifrangkeskou et al.
EMBO JOURNAL (2019)
Exploiting interconnected synthetic lethal interactions between PARP inhibition and cancer cell reversible senescence
Hubert Fleury et al.
NATURE COMMUNICATIONS (2019)
Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia
Woonbok Chung et al.
CLINICAL EPIGENETICS (2019)
Global patterns and trends in colorectal cancer incidence in young adults
Rebecca L. Siegel et al.
GUT (2019)
DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
Ssu-Chuan Lai et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
Kirill Bersuker et al.
NATURE (2019)
Mutations of R882 change flanking sequence preferences of the DNA methyltransferase DNMT3A and cellular methylation patterns
Max Emperle et al.
NUCLEIC ACIDS RESEARCH (2019)
DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load
Hyunchul Jung et al.
NATURE COMMUNICATIONS (2019)
Epigenetic synthetic lethality approaches in cancer therapy
Haoshen Yang et al.
CLINICAL EPIGENETICS (2019)
ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer
Jung-A Choi et al.
CANCERS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Combination treatment of acute myeloid leukemia cells with DNMT and HDAC inhibitors: predominant synergistic gene downregulation associated with gene body demethylation
Nadja Blagitko-Dorfs et al.
LEUKEMIA (2019)
Chromatin regulatory mechanisms and therapeutic opportunities in cancer
Alfredo M. Valencia et al.
NATURE CELL BIOLOGY (2019)
The Emerging Roles of RASSF5 in Human Malignancy
Shuofeng Li et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2018)
Screening for Ovarian Cancer Updated Evidence Report and Systematic Review for the US Preventive Services Task Force
Jillian T. Henderson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Altered DNA methyltransferases promoter methylation and mRNA expression are associated with tamoxifen response in breast tumors
Rosa Jahangiri et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
The role of DNA methylation in ageing and cancer
A. E. Morgan et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2018)
Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway
Lihui Wang et al.
CELL DEATH & DISEASE (2018)
Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma
Eric Hervouet et al.
CLINICAL EPIGENETICS (2018)
Shikonin Inhibites Migration and Invasion of Thyroid Cancer Cells by Downregulating DNMT1
Yue Zhang et al.
MEDICAL SCIENCE MONITOR (2018)
Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas
Hou-Shi Ma et al.
MEDICAL SCIENCE MONITOR (2018)
m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer
Jun Liu et al.
NATURE CELL BIOLOGY (2018)
Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells
Changjie Wu et al.
NATURE COMMUNICATIONS (2018)
DNA methylation and de-methylation using hybrid site-targeting proteins
Yong Lei et al.
GENOME BIOLOGY (2018)
Methylation-associated silencing of BASP1 contributes to leukemogenesis in t(8;21) acute myeloid leukemia
Lei Zhou et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Dose, Schedule, Safety, and Efficacy of Guadecitabine in Relapsed or Refractory Acute Myeloid Leukemia
Gail J. Roboz et al.
CANCER (2018)
Downregulation of DNMT3A by miR-708-5p Inhibits Lung Cancer Stem Cell-like Phenotypes through Repressing Wnt/beta-catenin Signaling
Tianchi Liu et al.
CLINICAL CANCER RESEARCH (2018)
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies
Edurne San Jose-Eneriz et al.
NATURE COMMUNICATIONS (2017)
Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities
Goran Micevic et al.
CLINICAL EPIGENETICS (2017)
Loss of Dnmt3a and Dnmt3b does not affect epidermal homeostasis but promotes squamous transformation through PPAR-γ
Lorenzo Rinaldi et al.
ELIFE (2017)
Targeting EZH2 in cancer therapy
Makoto Yamagishi et al.
CURRENT OPINION IN ONCOLOGY (2017)
Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening
E. Robert McDonald et al.
CELL (2017)
Genetic variations in cancer-related significantly mutated genes and lung cancer susceptibility
Y. Zhang et al.
ANNALS OF ONCOLOGY (2017)
Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer
Hanlin Zeng et al.
CANCER CELL (2016)
DNA Hypomethylation Contributes to Genomic Instability and Intestinal Cancer Initiation
Karyn L. Sheaffer et al.
CANCER PREVENTION RESEARCH (2016)
Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma
Simone Jueliger et al.
EPIGENETICS (2016)
Over-expression of DNMT3A predicts the risk of recurrent vulvar squamous cell carcinomas
Sarah Leonard et al.
GYNECOLOGIC ONCOLOGY (2016)
被撤回的出版物: Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis (Retracted article. See vol. 42, 2023)
Li Huang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
DNMT3a expression pattern and its prognostic value in lung adenocarcinoma
Ryan Edbert Husni et al.
LUNG CANCER (2016)
Promoter Hypomethylation and Expression Is Conserved in Mouse Chronic Lymphocytic Leukemia Induced by Decreased or Inactivated Dnmt3a
Staci L. Haney et al.
CELL REPORTS (2016)
Shikonin causes apoptosis by up-regulating p73 and down-regulating ICBP90 in human cancer cells
Soon Young Jang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
The tRNA methyltransferase Dnmt2 is required for accurate polypeptide synthesis during haematopoiesis
Francesca Tuorto et al.
EMBO JOURNAL (2015)
Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation
Tuncay Baubec et al.
NATURE (2015)
Methylation-independent repression of Dnmt3b contributes to oncogenic activity of Dnmt3a in mouse MYC-induced T-cell lymphomagenesis
S. L. Haney et al.
ONCOGENE (2015)
DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2
J. T. Poirier et al.
ONCOGENE (2015)
Overexpression of G9a and MCM7 in oesophageal squamous cell carcinoma is associated with poor prognosis
Xinwen Zhong et al.
HISTOPATHOLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Targeting DNA Methylation with Small Molecules: What's Next? Miniperspective
Alexandre Erdmann et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Structural insight into autoinhibition and histone H3-induced activation of DNMT3A
Xue Guo et al.
NATURE (2015)
Shikonin selectively induces apoptosis in human prostate cancer cells through the endoplasmic reticulum stress and mitochondrial apoptotic pathway
Rishi Kumar Gara et al.
JOURNAL OF BIOMEDICAL SCIENCE (2015)
Synthesis and Evaluation of Analogues of N-Phthaloyl-L-tryptophan (RG108) as Inhibitors of DNA Methyltransferase 1
Saadia Asgatay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Identifying Novel Selective Non-Nucleoside DNA Methyltransferase 1 Inhibitors through Docking-Based Virtual Screening
Shijie Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
SOCS3 methylation in synergy with Reg3A overexpression promotes cell growth in pancreatic cancer
Jun Wang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies
A. P. Im et al.
LEUKEMIA (2014)
Restoration of miR-101 suppresses lung tumorigenesis through inhibition of DNMT3a-dependent DNA methylation
F. Yan et al.
CELL DEATH & DISEASE (2014)
Epigenetic therapy in non-small-cell lung cancer: targeting DNA methyltransferases and histone deacetylases
Frank P. Vendetti et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Shikonin Inhibits Thyroid Cancer Cell Growth and Invasiveness Through Targeting Major Signaling Pathways
Qi Yang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression
Jun Gao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
DNMT3A mutation is a poor prognosis biomarker in AML: Results of a meta-analysis of 4500 AML patients
Velizar Shivarov et al.
LEUKEMIA RESEARCH (2013)
5-Aza-2'-deoxycytidine causes replication lesions that require Fanconi anemia-dependent homologous recombination for repair
Manuel Luis Orta et al.
NUCLEIC ACIDS RESEARCH (2013)
Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors
Olaf Neumann et al.
HEPATOLOGY (2012)
Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis
Ryan A. Hlady et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Epigenetic protein families: a new frontier for drug discovery
Cheryl H. Arrowsmith et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Dnmt3a Protects Active Chromosome Domains against Cancer-Associated Hypomethylation
Guenter Raddatz et al.
PLOS GENETICS (2012)
Genes methylated by DNA methyltransferase 3b are similar in mouse intestine and human colon cancer
Eveline J. Steine et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Molecular dynamics simulations of human DNA methyltransferase 3B with selective inhibitor nanaomycin A
Thomas Caulfield et al.
JOURNAL OF STRUCTURAL BIOLOGY (2011)
Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss
Christopher J. Klein et al.
NATURE GENETICS (2011)
Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia
Xiao-Jing Yan et al.
NATURE GENETICS (2011)
Deletion of the de novo DNA methyltransferase Dnmt3a promotes lung tumor progression
Qing Gao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Pancreatic cancer DNMT1 expression and sensitivity to DNMT1 inhibitors
Ang Li et al.
CANCER BIOLOGY & THERAPY (2010)
Dysregulation of p53/Sp1 Control Leads to DNA Methyltransferase-1 Overexpression in Lung Cancer
Ruo-Kai Lin et al.
CANCER RESEARCH (2010)
The Dnmt3a PWWP Domain Reads Histone 3 Lysine 36 Trimethylation and Guides DNA Methylation
Arunkumar Dhayalan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Multicenter, Phase II Study of Decitabine for the First-Line Treatment of Older Patients With Acute Myeloid Leukemia
Amanda F. Cashen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Nanaomycin A Selectively Inhibits DNMT3B and Reactivates Silenced Tumor Suppressor Genes in Human Cancer Cells
Dirk Kuck et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Epigenetic Reprogramming in Plant and Animal Development
Suhua Feng et al.
SCIENCE (2010)
An essential role for DNA methyltransferase 3a in melanoma tumorigenesis
Tao Deng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Combined inhibition of DNA methylation and histone acetylation enhances gene re-expression and drug sensitivity in vivo
N. Steele et al.
BRITISH JOURNAL OF CANCER (2009)
Combined inhibition of Dnmt and mTOR signaling inhibits formation and growth of colorectal cancer
Yan-Jie Zhang et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2009)
Dynamic interaction between WT1 and BASP1 in transcriptional regulation during differentiation
Laura M. Green et al.
NUCLEIC ACIDS RESEARCH (2009)
DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines
J. Devon Roll et al.
MOLECULAR CANCER (2008)
Formation of nucleoprotein filaments by mammalian DNA methyltransferase Dnmt3a in complex with regulator Dnmt3L
Renata Z. Jurkowska et al.
NUCLEIC ACIDS RESEARCH (2008)
Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing
Heinz G. Linhart et al.
GENES & DEVELOPMENT (2007)
Covalent modification of DNA regulates memory formation
Courtney A. Miller et al.
NEURON (2007)
The role of HOX genes in malignant myeloid disease
Elizabeth A. Eklund
CURRENT OPINION IN HEMATOLOGY (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers
Jairo Rodriguez et al.
CANCER RESEARCH (2006)
Non-coding RNA
JS Mattick et al.
HUMAN MOLECULAR GENETICS (2006)
Suppression of intestinal neoplasia by deletion of Dnmt3b
HJ Lin et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Distinct DNA methylation activity of Dnmt3a and Dnmt3b towards naked and nucleosomal DNA
H Takeshima et al.
JOURNAL OF BIOCHEMISTRY (2006)
The concept of synthetic lethality in the context of anticancer therapy
WG Kaelin
NATURE REVIEWS CANCER (2005)
Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers
T Etoh et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Biochemistry and biology of mammalian DNA methyltransferases
A Hermann et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
The PWWP domain of Dnmt3a and Dnmt3b is required for directing DNA methylation to the major satellite repeats at pericentric heterochromatin
TP Chen et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Epigenetics in human disease and prospects for epigenetic therapy
G Egger et al.
NATURE (2004)
Mutation of the DNA methyltransferase (DNMT) 1 gene in human colorectal cancers
Y Kanai et al.
CANCER LETTERS (2003)
The fundamental role of epigenetic events in cancer
PA Jones et al.
NATURE REVIEWS GENETICS (2002)
The DNMT1 target recognition domain resides in the N terminus
FD Araujo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Share Paper
